Line 42: | Line 42: | ||
Since we are both working on protein production in E.coli we started a collaboration with iGEM Lund. During this collaboration we exchanged biobricks in order to verify them. We also tested any interaction between our plasmid <a target="_blank" style="color:blue" href="http://parts.igem.org/Part:BBa_K2671337">BBa_K2671337</a> (GroES) and their <a target="_blank" style="color:blue" href="http://parts.igem.org/Part:BBa_K2602021">BBa_K2602021</a> (VHb-GFP) plasmid. | Since we are both working on protein production in E.coli we started a collaboration with iGEM Lund. During this collaboration we exchanged biobricks in order to verify them. We also tested any interaction between our plasmid <a target="_blank" style="color:blue" href="http://parts.igem.org/Part:BBa_K2671337">BBa_K2671337</a> (GroES) and their <a target="_blank" style="color:blue" href="http://parts.igem.org/Part:BBa_K2602021">BBa_K2602021</a> (VHb-GFP) plasmid. | ||
</h4> | </h4> | ||
− | + | <br> | |
− | + | <br> | |
<h1> | <h1> | ||
Human Practice Collaborations | Human Practice Collaborations | ||
</h1> | </h1> | ||
− | + | <br> | |
<h3> | <h3> | ||
Podcast - a Collaboration with iGEM Chalmers | Podcast - a Collaboration with iGEM Chalmers |
Revision as of 09:53, 13 October 2018